» Articles » PMID: 22735797

Phenotypic and Functional Comparison Between Flask Adherent and Magnetic Activated Cell Sorted Monocytes Derived Dendritic Cells

Overview
Journal Iran J Immunol
Date 2012 Jun 28
PMID 22735797
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Generation of an effective dendritic cell (DC) based cancer vaccine depends on appropriate differentiation of monocytes in vitro.

Objective: To compare the effects of monocyte separation methods, flask adherence (Flask-DC) and magnetic activated cell sorting (MACS-DC), on phenotypic and functional characteristics of resultant DCs.

Methods: DCs from healthy volunteers were generated from plastic adherence and MACS isolated monocytes in the presence of GM-CSF and IL-4 as well as TNF-α and monocyte conditioned medium (MCM) in 7 day cultures. Mature DCs were then subjected to phenotypic analysis using anti-CD14, anti-CD83 and HLA-DR monoclonal antibodies. Functional and cytokine release assays were carried out using [3H] thymidine uptake test and commercially available ELISA kits for the determination of IL-12, IL-10, IFN-γ and IL-4, respectively.

Results: We found that MACS-DCs were more homogenous and the yield and viability were fairly higher than Flask-DCs. MACS-DCs expressed higher levels of CD83 and HLA-DR as well as CD14 compared to the Flask-DCs. Induction of T cell proliferative responses were higher in Flask-DCs and also they elicited higher levels of IL-12: IL-10 and IFN-γ: IL-4 ratios in cytokine generation assays.

Conclusion: MACS method was superior for mass production of viable homogenous and fully mature DCs but their cytokine profile had the potential to polarize the immune system toward Th2 type immune response.

Citing Articles

A protocol to isolate and characterize pure monocytes and generate monocyte-derived dendritic cells through FBS-Coated flasks.

Meskini M, Amanzadeh A, Salehi F, Bouzari S, Karimipoor M, Fuso A Sci Rep. 2024; 14(1):23956.

PMID: 39397067 PMC: 11471755. DOI: 10.1038/s41598-024-75376-3.


Optimization and Validation of a Harmonized Protocol for Generating Therapeutic-Grade Dendritic Cells in a Randomized Phase II Clinical Trial, Using Two Varied Antigenic Sources.

Seetharaman A, Christopher V, Dhandapani H, Jayakumar H, Dhanushkodi M, Bhaskaran N Vaccines (Basel). 2024; 12(2).

PMID: 38400096 PMC: 10892253. DOI: 10.3390/vaccines12020112.


The synergistic and enhancive effects of IL-6 and M-CSF to expand and differentiate functional dendritic cells from human monocytes under serum-free condition.

Yao C, Tseng T J Biol Eng. 2023; 17(1):6.

PMID: 36703209 PMC: 9881386. DOI: 10.1186/s13036-023-00325-z.


Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition).

Cossarizza A, Chang H, Radbruch A, Acs A, Adam D, Adam-Klages S Eur J Immunol. 2019; 49(10):1457-1973.

PMID: 31633216 PMC: 7350392. DOI: 10.1002/eji.201970107.


Monocyte isolation techniques significantly impact the phenotype of both isolated monocytes and derived macrophages in vitro.

Nielsen M, Andersen M, Moller H Immunology. 2019; 159(1):63-74.

PMID: 31573680 PMC: 6904589. DOI: 10.1111/imm.13125.